Pebp-2 Inhibitors
Pebp-2 inhibitors belong to a category of chemical agents that interact with phosphatidylethanolamine-binding protein 2 (PEBP-2), a protein that is part of a wider family known for their affinity towards phosphatidylethanolamine (PE) and similar biologically active molecules. The role of Pebp-2 is significant in various cellular functions due to its interaction with PE, a compound essential in the structure and function of cell membranes, signaling pathways, and the regulation of certain enzyme activities. Inhibitors targeting Pebp-2 are structured to alter its activity by binding to specific sites on the protein, which can change the protein's shape and subsequently its interaction with PE and other molecules. This alteration can influence Pebp-2's normal activity, which encompasses its involvement in the transmission of cellular signals and the preservation of cellular equilibrium.
The development of Pebp-2 inhibitors leverages a detailed comprehension of the Pebp-2 structure, especially the sites where PE and other ligands bind. Advanced techniques like X-ray crystallography or NMR spectroscopy are utilized to determine the protein's three-dimensional conformation and to pinpoint essential amino acids that are involved in ligand attachment. Pebp-2 inhibitors might be designed to resemble the natural ligands of Pebp-2 or could be original compounds identified through various discovery methods. The binding dynamics between these inhibitors and Pebp-2 can be examined using techniques such as surface plasmon resonance or isothermal titration calorimetry, providing data on the strength, kinetics, and thermodynamic properties of the interaction. The focus on Pebp-2 inhibitors is rooted in their unique ability to modulate the activity of Pebp-2, which, in turn, can lead to changes in the cellular activities where Pebp-2 plays a pivotal role.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. It inhibits multiple kinases that could phosphorylate Pebp-2, thereby decreasing Pebp-2 functional activity as phosphorylation is often key to protein activation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a phosphoinositide 3-kinases (PI3K) inhibitor. By inhibiting PI3K, it prevents the activation of downstream targets that may be involved in the post-translational modification or localization of Pebp-2, thus leading to its decreased activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a specific inhibitor of mitogen-activated protein kinase kinase (MEK), which is a part of the MAPK/ERK pathway. Inhibiting this pathway could prevent the activation of downstream effectors that modulate Pebp-2 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor. By inhibiting mTOR, it disrupts downstream signaling that may be crucial for the proper functioning or expression of Pebp-2. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAPK. By inhibiting p38 MAPK, it could indirectly decrease the activity of Pebp-2 if Pebp-2 is a downstream effector in the p38 MAPK pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor. By blocking PI3K activity, it could lead to reduced activation of downstream proteins that interact with or regulate Pebp-2, thereby decreasing Pebp-2 activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, key components of the MAPK/ERK pathway. By inhibiting this pathway, it could prevent the phosphorylation and activation of proteins that could affect the function of Pebp-2. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK). Inhibition of JNK could lead to the inactivation of transcription factors or other proteins that regulate the expression or activity of Pebp-2. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Imatinib is a tyrosine kinase inhibitor. By inhibiting certain tyrosine kinases, it could prevent the phosphorylation and activation of proteins that are required for Pebp-2 functional activity. | ||||||
NF 449 | 389142-38-5 | sc-203159 | 10 mg | $314.00 | 5 | |
NF449 is a potent and selective antagonist of Gαs subunit of G proteins. Inhibition of Gαs could affect cAMP levels, potentially affecting signaling pathways that regulate Pebp-2 activity. | ||||||